707 related articles for article (PubMed ID: 31401389)
1. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Disorders and Cancer: Hepatocyte Store-Operated Ca
Ali ES; Rychkov GY; Barritt GJ
Adv Exp Med Biol; 2017; 993():595-621. PubMed ID: 28900935
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial metabolism and calcium homeostasis in the development of NAFLD leading to hepatocellular carcinoma.
Bhowmick S; Singh V; Jash S; Lal M; Sinha Roy S
Mitochondrion; 2021 May; 58():24-37. PubMed ID: 33581332
[TBL] [Abstract][Full Text] [Related]
4. Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism.
Wilson CH; Ali ES; Scrimgeour N; Martin AM; Hua J; Tallis GA; Rychkov GY; Barritt GJ
Biochem J; 2015 Mar; 466(2):379-90. PubMed ID: 25422863
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.
Ma C; Zhang Q; Greten TF
FEBS J; 2018 Feb; 285(4):752-762. PubMed ID: 28857485
[TBL] [Abstract][Full Text] [Related]
6. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
7. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
9. The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes.
Ali ES; Hua J; Wilson CH; Tallis GA; Zhou FH; Rychkov GY; Barritt GJ
Biochim Biophys Acta; 2016 Sep; 1863(9):2135-46. PubMed ID: 27178543
[TBL] [Abstract][Full Text] [Related]
10. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.
Chen J; Chen J; Huang J; Li Z; Gong Y; Zou B; Liu X; Ding L; Li P; Zhu Z; Zhang B; Guo H; Cai C; Li J
Aging (Albany NY); 2019 Dec; 11(23):10839-10860. PubMed ID: 31796646
[TBL] [Abstract][Full Text] [Related]
12. Lipid droplets disrupt mechanosensing in human hepatocytes.
Chin L; Theise ND; Loneker AE; Janmey PA; Wells RG
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G11-G22. PubMed ID: 32463334
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
14. Upregulated SOCC and IP3R calcium channels and subsequent elevated cytoplasmic calcium signaling promote nonalcoholic fatty liver disease by inhibiting autophagy.
Zhang L; Zhang Y; Jiang Y; Dou X; Li S; Chai H; Qian Q; Wang M
Mol Cell Biochem; 2021 Aug; 476(8):3163-3175. PubMed ID: 33864571
[TBL] [Abstract][Full Text] [Related]
15. CISD2 Haploinsufficiency Disrupts Calcium Homeostasis, Causes Nonalcoholic Fatty Liver Disease, and Promotes Hepatocellular Carcinoma.
Shen ZQ; Chen YF; Chen JR; Jou YS; Wu PC; Kao CH; Wang CH; Huang YL; Chen CF; Huang TS; Shyu YC; Tsai SF; Kao LS; Tsai TF
Cell Rep; 2017 Nov; 21(8):2198-2211. PubMed ID: 29166610
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
17. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD).
Flessa CM; Kyrou I; Nasiri-Ansari N; Kaltsas G; Kassi E; Randeva HS
J Cell Biochem; 2022 Oct; 123(10):1585-1606. PubMed ID: 35490371
[TBL] [Abstract][Full Text] [Related]
19. Impaired Ca
Ali ES; Girard D; Petrovsky N
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C187-C198. PubMed ID: 34106786
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.
Fontes A; Alemany-Pagès M; Oliveira PJ; Ramalho-Santos J; Zischka H; Azul AM
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
